These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15054045)

  • 1. Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation.
    Chen J; Williams IR; Kutok JL; Duclos N; Anastasiadou E; Masters SC; Fu H; Gilliland DG
    Blood; 2004 Jul; 104(2):535-42. PubMed ID: 15054045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways.
    Sternberg DW; Tomasson MH; Carroll M; Curley DP; Barker G; Caprio M; Wilbanks A; Kazlauskas A; Gilliland DG
    Blood; 2001 Dec; 98(12):3390-7. PubMed ID: 11719379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22).
    Schwaller J; Anastasiadou E; Cain D; Kutok J; Wojiski S; Williams IR; LaStarza R; Crescenzi B; Sternberg DW; Andreasson P; Schiavo R; Siena S; Mecucci C; Gilliland DG
    Blood; 2001 Jun; 97(12):3910-8. PubMed ID: 11389034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
    Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
    J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.
    Magnusson MK; Meade KE; Brown KE; Arthur DC; Krueger LA; Barrett AJ; Dunbar CE
    Blood; 2001 Oct; 98(8):2518-25. PubMed ID: 11588050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation.
    Irusta PM; DiMaio D
    EMBO J; 1998 Dec; 17(23):6912-23. PubMed ID: 9843497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.
    Ross TS; Gilliland DG
    J Biol Chem; 1999 Aug; 274(32):22328-36. PubMed ID: 10428802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin.
    Chen J; Wall NR; Kocher K; Duclos N; Fabbro D; Neuberg D; Griffin JD; Shi Y; Gilliland DG
    J Clin Invest; 2004 Jun; 113(12):1784-91. PubMed ID: 15199413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The coupling of TEL/PDGFbetaR to distinct functional responses is modulated by the presence of cytokine: involvement of mitogen-activated protein kinases.
    Wheadon H; Welham MJ
    Blood; 2003 Aug; 102(4):1480-9. PubMed ID: 12714513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins.
    Wilbanks AM; Mahajan S; Frank DA; Druker BJ; Gilliland DG; Carroll M
    Exp Hematol; 2000 May; 28(5):584-93. PubMed ID: 10812249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).
    Ross TS; Bernard OA; Berger R; Gilliland DG
    Blood; 1998 Jun; 91(12):4419-26. PubMed ID: 9616134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.
    Carroll M; Tomasson MH; Barker GF; Golub TR; Gilliland DG
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14845-50. PubMed ID: 8962143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor.
    Tomasson MH; Williams IR; Hasserjian R; Udomsakdi C; McGrath SM; Schwaller J; Druker B; Gilliland DG
    Blood; 1999 Mar; 93(5):1707-14. PubMed ID: 10029600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein.
    Sjöblom T; Boureux A; Rönnstrand L; Heldin CH; Ghysdael J; Ostman A
    Oncogene; 1999 Nov; 18(50):7055-62. PubMed ID: 10597306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3.
    Tomasson MH; Williams IR; Li S; Kutok J; Cain D; Gillessen S; Dranoff G; Van Etten RA; Gilliland DG
    Blood; 2001 Mar; 97(5):1435-41. PubMed ID: 11222391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.
    Cain JA; Xiang Z; O'Neal J; Kreisel F; Colson A; Luo H; Hennighausen L; Tomasson MH
    Blood; 2007 May; 109(9):3906-14. PubMed ID: 17218386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of an inhibitory juxtamembrane WW-like domain in the platelet-derived growth factor beta receptor.
    Irusta PM; Luo Y; Bakht O; Lai CC; Smith SO; DiMaio D
    J Biol Chem; 2002 Oct; 277(41):38627-34. PubMed ID: 12181311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
    Kulkarni S; Heath C; Parker S; Chase A; Iqbal S; Pocock CF; Kaeda J; Cwynarski K; Goldman JM; Cross NC
    Cancer Res; 2000 Jul; 60(13):3592-8. PubMed ID: 10910073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein.
    Besançon F; Atfi A; Gespach C; Cayre YE; Bourgeade MF
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8081-6. PubMed ID: 9653143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of the platelet-derived growth factor receptor (PDGFR) beta transmembrane domain in the TEL-PDGFRbeta cytosolic oncoprotein.
    Toffalini F; Hellberg C; Demoulin JB
    J Biol Chem; 2010 Apr; 285(16):12268-78. PubMed ID: 20164181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.